Figure 1
Ligand-binding Pocket model.
Note: Green refers to sorafenib; Yellow refers to gleevec; Blue refers to tarceva. A novel series of compounds were synthesized as inhibitors of tyrosine kinases serine/threonine-protein kinases.
Figure 1 | Scientific Reports
